- Home
- SSKN vs ADIL Comparison
SSKN vs ADIL Comparison
Compare SSKN & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- ADIL
- Stock Information
- Founded
- SSKN 1989
- ADIL 2010
- Country
- SSKN United States
- ADIL United States
- Employees
- SSKN N/A
- ADIL N/A
- Industry
- SSKN Medical/Dental Instruments
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- ADIL Health Care
- Exchange
- SSKN Nasdaq
- ADIL Nasdaq
- Market Cap
- SSKN 8.9M
- ADIL 7.6M
- IPO Year
- SSKN 2005
- ADIL 2018
- Fundamental
- Price
- SSKN $1.40
- ADIL $0.35
- Analyst Decision
- SSKN Strong Buy
- ADIL Strong Buy
- Analyst Count
- SSKN 1
- ADIL 1
- Target Price
- SSKN $6.00
- ADIL $8.00
- AVG Volume (30 Days)
- SSKN 2.9M
- ADIL 553.7K
- Earning Date
- SSKN 11-12-2025
- ADIL 11-12-2025
- Dividend Yield
- SSKN N/A
- ADIL N/A
- EPS Growth
- SSKN N/A
- ADIL N/A
- EPS
- SSKN N/A
- ADIL N/A
- Revenue
- SSKN $32,848,000.00
- ADIL N/A
- Revenue This Year
- SSKN N/A
- ADIL N/A
- Revenue Next Year
- SSKN $9.70
- ADIL N/A
- P/E Ratio
- SSKN N/A
- ADIL N/A
- Revenue Growth
- SSKN 0.36
- ADIL N/A
- 52 Week Low
- SSKN $1.38
- ADIL $0.22
- 52 Week High
- SSKN $3.86
- ADIL $1.30
- Technical
- Relative Strength Index (RSI)
- SSKN 37.68
- ADIL 37.05
- Support Level
- SSKN $1.52
- ADIL $0.34
- Resistance Level
- SSKN $1.70
- ADIL $0.38
- Average True Range (ATR)
- SSKN 0.39
- ADIL 0.02
- MACD
- SSKN -0.05
- ADIL 0.00
- Stochastic Oscillator
- SSKN 0.81
- ADIL 11.67
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.